Cui Cui

Chinese drug makers’ licensing deals more than doubled in 2025 from a year earlier to a record high, propelled by…

If pharmaceutical drug patents are an hourglass turned over on the day of approval – with the approaching loss of…

China’s cost and efficiency advantages in drug development have been recognised at the world’s largest cancer research conference in the…

Chinese biotech firm Akeso, whose cancer drug has been hailed as a breakthrough for the nation’s pharmaceutical industry, suffered a…